Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

A novel treatment, an aldosterone synthase inhibitor, safely and consistently lowered blood pressure in individuals with ...

New drug lorundrostat shows promising results in lowering blood pressure for patients with resistant hypertension.

The data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, ...

Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with heart ...

Most people assume that when blood pressure stays high despite medication, it’s due to stress or an incorrect dose. But resistant hypertension is a specific clinical condition. It means one’s blood ...

Agarwal explains that low levels of a hormone called aldosterone might be behind your constant urge to eat salty food. In her words, “Your cravings are your body’s way of whispering what it needs.

Mineralys has reported outcomes from its pivotal randomised, placebo-controlled Phase III Launch-HTN trial assessing ...

In a country where nearly 1 in 3 adults silently battles high blood pressure , the need for regular blood pressure monitoring ...